Atossa Therapeutics, Inc. (ATOS) NASDAQ
4.85
-0.26(-5.09%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.85
-0.26(-5.09%)
Currency In USD
| Market Cap | 76.21M |
| Enterprise Value | 34.91M |
| P/E Ratio | -1.11 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.37 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.26 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.99 |
| Return On Equity | -0.85 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -37.13M |
| Net Income | -34.77M |
| Diluted EPS | -4.04 |
| Total Cash | 31.72M |
| Total Cash/Share | 3.68 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 4.92 |
| Book Value Per Share | 3.54 |
| 52-Week Change | -62.69 |
| 52-Week High | 19.35 |
| 52-Week Low | 3.76 |
| Moving Average 50 Days | 5.29 |
| Moving Average 200 Days | 9.05 |
| Average Volume | 64,457 |
| Shares Outstanding | 8.61M |
| % Held by Institutions | 14.38 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | February 02, 2026 |